These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17409796)

  • 1. Lung cancer in HIV-infected patients in the era of highly active antiretroviral therapy.
    Hakimian R; Fang H; Thomas L; Edelman MJ
    J Thorac Oncol; 2007 Apr; 2(4):268-72. PubMed ID: 17409796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study.
    Rengan R; Mitra N; Liao K; Armstrong K; Vachani A
    Lancet Oncol; 2012 Dec; 13(12):1203-9. PubMed ID: 23164952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration.
    D'Jaen GA; Pantanowitz L; Bower M; Buskin S; Neil N; Greco EM; Cooley TP; Henry D; Stem J; Dezube BJ; Stebbing J; Aboulafia DM
    Clin Lung Cancer; 2010 Nov; 11(6):396-404. PubMed ID: 21062730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer.
    Lavolé A; Chouaïd C; Baudrin L; Wislez M; Raguin G; Pialoux G; Girard PM; Milleron B; Cadranel J
    Lung Cancer; 2009 Sep; 65(3):345-50. PubMed ID: 19135758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART?
    Powles T; Thirwell C; Newsom-Davis T; Nelson M; Shah P; Cox S; Gazzard B; Bower M
    Br J Cancer; 2003 Aug; 89(3):457-9. PubMed ID: 12888811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort study.
    Makinson A; Tenon JC; Eymard-Duvernay S; Pujol JL; Allavena C; Cuzin L; Poizot-Martin I; de la Tribonnière X; Cabié A; Pugliese P; Reynes J; Le Moing V
    J Thorac Oncol; 2011 Jun; 6(6):1022-9. PubMed ID: 21512403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer in HIV positive patients: the GICAT experience.
    Bearz A; Vaccher E; Martellotta F; Spina M; Talamini R; Lleshi A; Cacopardo B; Nunnari G; Berretta M; Tirelli U;
    Eur Rev Med Pharmacol Sci; 2014; 18(4):500-8. PubMed ID: 24610616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of Japanese lung cancer patients with human immunodeficiency virus infection.
    Okuma Y; Yanagisawa N; Takagi Y; Hosomi Y; Suganuma A; Imamura A; Iguchi M; Okamura T; Ajisawa A; Shibuya M
    Int J Clin Oncol; 2012 Oct; 17(5):462-9. PubMed ID: 21918928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
    Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
    Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
    Wong KH; Chan KC; Lee SS
    Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auditing a new lung cancer service.
    Cullen JP; Glynn C; Murtagh E; Hogan B; Jeffers M; Lane SJ
    Ir Med J; 2004 Oct; 97(9):281-3. PubMed ID: 15568588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer risk in people infected with human immunodeficiency virus in the United States.
    Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
    Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features of lung cancer HIV-infected patients].
    Kato T; Ieki R; Saito E; Ot T; Yuasa K; Iguchi M; Okamura T; Shibuya M; Ajisawa A
    Nihon Kokyuki Gakkai Zasshi; 2007 Sep; 45(9):661-6. PubMed ID: 17929466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-related lung cancer -- a growing concern?
    Powles T; Nelson M; Bower M
    Int J STD AIDS; 2003 Oct; 14(10):647-51. PubMed ID: 14596765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
    Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
    Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
    Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era.
    Chiao EY; Giordano TP; Richardson P; El-Serag HB
    J Clin Oncol; 2008 Jan; 26(3):474-9. PubMed ID: 18202423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.